glp 1 sleep apnea Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes Sleep Apnea: GLP-1 Drug Zepbound

Description

After propensity score matching, each cohort included 4,912 patients balanced for age, sex, race, BMI, diabetes, cardiovascular risk factors, and immunosuppressive medication use

Government-insurance patients are typically excluded from manufacturer cards

While rare complications like gastroparesis (stomach paralysis) or pancreatitis can occur, they are uncommon

Some have proposed miRNAs as biomarkers for predicting how well diabetic medications will work [161]

What the published research reported A phase-2 randomized trial published in the New England Journal of Medicine in 2023 studied retatrutide in adults with obesity and reported substantial, dose-dependent reductions in body weight over 48 weeks, alongside a gastrointestinal side-effect profile broadly similar to other incretin drugs